Avesthagen scouting for partners for bioactive ingredients
Life sciences firm Avesthagen is scouting for partners for marketing of its bioactive ingredient products globally.
LONDON, Sept. 23, 2010-The European Medicines Agency today recommended the suspension of the marketing authorisations for the rosiglitazone-containing anti-diabetes medicines Avandia, Avandamet and Avaglim.